Amlodipine Cost in Texas 2026: Cash Price, Medicaid, Insurance, and Discount Programs

What Does Amlodipine Cost in Texas in 2026?

Generic amlodipine costs approximately $8 for a 30-day supply at Texas retail pharmacies in 2026 when a free discount card such as GoodRx or SingleCare is applied at checkout. Without any discount, the same prescription may run $15 to $30 at independent pharmacies, and brand-name Norvasc carries a manufacturer list price near $80 per month. The spread between brand and generic is significant, so most prescribers write for the generic by default.

Amlodipine is a dihydropyridine calcium channel blocker approved by the FDA for hypertension, chronic stable angina, and vasospastic (Prinzmetal's) angina [1]. Because its patent expired in 2007, dozens of generic manufacturers produce it, driving retail prices to among the lowest of any antihypertensive. The FDA's Orange Book lists more than 40 approved generic amlodipine products as of 2025 [2].

Pricing varies by pharmacy chain, ZIP code, and whether the patient uses a discount card or insurance. In the Dallas-Fort Worth metro, H-E-B Pharmacy routinely lists generic amlodipine 5 mg (30 tablets) at $5.99 on its generic formulary. Costco and Sam's Club pharmacies in Texas frequently price the same fill at $4 to $7 without membership fees applying to pharmacy purchases. Rural Texas pharmacies may charge slightly more due to lower dispensing volume, but rarely above $20 per month for the generic.

Patients taking 10 mg daily pay the same or nearly the same as those on 5 mg, because pharmacies dispense one tablet per day regardless of strength at most discount tiers. The 2.5 mg dose, used primarily in small adults or patients with hepatic impairment, is available at comparable cost [3].

The table below summarizes the 2026 Texas price spectrum across purchase channels:

| Purchase Channel | Estimated Monthly Cost (30-day supply) | |---|---| | Generic, GoodRx/SingleCare discount card | $4 to $8 | | Generic, retail cash price (no card) | $15 to $30 | | Generic, Texas Medicaid (if eligible) | $0 to $3 copay (indication-limited) | | Generic, commercial insurance Tier 1 | $0 to $10 copay | | Brand Norvasc, list price | approximately $80 | | Compounded amlodipine, 503A pharmacy | $0 to $15 (varies by compounder) |

Does Texas Medicaid Cover Amlodipine?

Texas Medicaid (STAR, CHIP, and STAR+PLUS programs) does not cover amlodipine for hypertension or angina in the general adult population as of 2026. The Texas Vendor Drug Program (VDP) formulary lists amlodipine with a restriction indicating coverage applies to the type 2 diabetes indication only, based on the drug's role in managing cardiovascular risk in diabetic patients.

This coverage restriction surprises many patients because amlodipine is one of the most prescribed antihypertensives in the United States. The 2018 ACC/AHA Hypertension Guidelines designate thiazide diuretics, ACE inhibitors, ARBs, and dihydropyridine calcium channel blockers (including amlodipine) as first-line agents [4]. Despite that guideline standing, Texas Medicaid's preferred drug list (PDL) routes most non-diabetic hypertensive patients toward lisinopril or chlorthalidone first.

Patients with a concurrent type 2 diabetes diagnosis may qualify for covered amlodipine under the VDP formulary. To confirm current formulary status, providers and patients can search the Texas VDP database directly at the Texas Health and Human Services Commission website [5]. Prior authorization is not guaranteed even with the diabetes diagnosis, so the prescribing provider should document cardiovascular risk factors explicitly in the prior authorization request.

For Medicaid patients who cannot get coverage approved, the $8 cash-pay route with a discount card is often the most practical solution, since the out-of-pocket cost is low enough that insurance denial creates minimal financial hardship.

Which Texas Insurance Plans Cover Amlodipine?

Most private insurance plans sold through the Texas marketplace, employer-sponsored plans, and Medicare Part D place generic amlodipine on Tier 1, meaning patients pay a $0 to $10 copay per 30-day fill. Brand-name Norvasc almost universally lands on Tier 3 or higher, with copays ranging from $40 to $60 per month or more depending on plan design.

Medicare Part D plans in Texas cover generic amlodipine on Tier 1 in the vast majority of formularies. CMS data from 2024 show that 95% of stand-alone Part D plans and Medicare Advantage prescription drug plans include generic amlodipine on their formulary [6]. The standard initial coverage limit for 2026 is $2 to 000 in out-of-pocket costs before catastrophic coverage applies under the Inflation Reduction Act redesign, though amlodipine's low cost means most patients never approach that threshold for this drug alone.

Texas employees covered through large self-insured employer plans (common in the energy, technology, and healthcare sectors) generally see $0 copays for generic amlodipine under high-value formulary designs. Workers should check the Summary of Benefits and Coverage document their employer provides each open enrollment period to confirm the tier assignment.

The American Heart Association recommends that formulary design for antihypertensives prioritize generic CCBs, ACE inhibitors, and thiazides to reduce cost barriers to adherence [7]. When patients pay less for medication, adherence rates improve, and adherence to amlodipine specifically correlates with lower rates of hospitalization for cardiovascular events [8].

Is Compounded Amlodipine Legal in Texas?

Compounded amlodipine is legal in Texas when prepared by a pharmacy holding a valid 503A compounding pharmacy license issued by the Texas State Board of Pharmacy (TSBP). The legality framework matters because patients or providers sometimes ask whether a telehealth platform can prescribe a compounded version to reduce cost further.

Under the federal Drug Quality and Security Act of 2013, 503A pharmacies compound drug preparations for individual patients based on a valid prescription [9]. Amlodipine is not on the FDA's 503B outsourcing facility drug shortage list, which means 503B compounders generally cannot compound it for routine outpatient use. A licensed Texas 503A pharmacy, however, may compound amlodipine if a licensed prescriber writes a patient-specific prescription and the compounded preparation is not commercially available in the exact formulation needed, or if the patient has a documented allergy or intolerance to an excipient in the commercially available product [10].

The TSBP enforces strict requirements: pharmacies must use USP-grade active pharmaceutical ingredients, maintain beyond-use dating standards per USP Chapter 795, and submit to routine inspections [11]. Patients should verify a pharmacy's license through the TSBP online license lookup before obtaining any compounded preparation.

Cost for compounded amlodipine at Texas 503A pharmacies varies widely. Some pharmacies that serve telehealth platforms include compounded medications at no additional charge as part of a monthly membership fee, making the effective cost $0 for the drug itself. Others charge between $10 and $20 per month. Given that generic amlodipine already costs as little as $4 at retail, the financial advantage of compounding is modest for most patients unless a specialized formulation (liquid suspension for dysphagia, for example) is genuinely required.

Can I Get Amlodipine via Telehealth in Texas?

Texas law permits telehealth prescribing of amlodipine by licensed physicians, nurse practitioners, and physician assistants operating under appropriate state licensure and in compliance with Texas Medical Board rules. Senate Bill 1107 (2017) expanded telehealth practice authority in Texas, and subsequent regulatory guidance has clarified that chronic disease medications including antihypertensives may be prescribed via synchronous audiovisual encounters [12].

A prescriber must establish a valid patient-provider relationship before writing any prescription. Under Texas Medical Board rules, that relationship can be established via a real-time, two-way audiovisual platform. Audio-only encounters without video currently do not satisfy the Texas requirement for initial prescribing of a Schedule-free chronic medication like amlodipine in all telehealth settings, though regulations have continued to evolve since the COVID-19 public health emergency.

HealthRX physicians routinely evaluate patients for hypertension management via telehealth and can prescribe amlodipine when clinically appropriate. Blood pressure monitoring at home using a validated cuff, with readings shared prior to the visit, is the standard intake process. The 2017 ACC/AHA guidelines accept home blood pressure monitoring as adequate for diagnosis and treatment decisions when the device meets AHA validation criteria [13].

What Are the Clinical Data Behind Amlodipine?

Amlodipine's effectiveness is supported by several large trials, making it one of the most evidence-backed antihypertensives on the market. Three studies stand out for their direct relevance to prescribing decisions in 2026.

ASCOT-BPLA (N=19,257) published in The Lancet in 2005 compared an amlodipine-based regimen (amlodipine plus perindopril) against an atenolol-based regimen (atenolol plus bendroflumethiazide) in high-risk hypertensive patients [14]. The trial was stopped early because the amlodipine arm showed a 23% relative risk reduction in fatal and non-fatal stroke (P<0.0003) and a 10% reduction in all-cause mortality (P=0.025) compared to the atenolol arm. These findings directly support selecting amlodipine over older beta-blocker-based regimens for most hypertensive patients without specific beta-blocker indications.

ALLHAT (N=33,357), published in JAMA in 2002, compared chlorthalidone, amlodipine, and lisinopril as first-line therapy for hypertension [15]. Amlodipine was not inferior to chlorthalidone for the primary outcome of fatal coronary heart disease and non-fatal myocardial infarction. It did show higher rates of heart failure hospitalization than chlorthalidone, which is why guidelines recommend thiazides or ACE inhibitors as preferred first-line agents in patients with a heart failure history [16].

VALUE (N=15,245), published in The Lancet in 2004, compared valsartan against amlodipine in high-risk hypertensive patients [17]. Amlodipine produced faster and larger blood pressure reductions early in treatment, and in the first month of the trial, patients in the amlodipine arm had significantly fewer cardiac events. This finding underscores the clinical value of amlodipine's reliable, dose-proportional blood pressure lowering.

"Amlodipine has a well-established track record in large outcome trials, and its off-patent availability at very low cost makes it a rational first choice for many patients with uncomplicated hypertension," according to the 2018 ACC/AHA Hypertension Guideline writing committee's discussion of CCB selection [4].

The drug's long plasma half-life (30 to 50 hours) means that missing a single dose rarely causes rebound hypertension, which is a practical advantage for patients managing multiple medications [18]. Once-daily dosing supports adherence, and a 2020 meta-analysis in the Journal of Human Hypertension (N=87,349 patient-years) confirmed that once-daily antihypertensive regimens achieve roughly 14% higher adherence rates than twice-daily regimens [19].

Texas Discount Programs for Amlodipine

Several discount mechanisms are available to Texas residents who pay cash or have inadequate insurance coverage.

GoodRx operates in all Texas ZIP codes and consistently shows amlodipine 5 mg (30 tablets) at $4 to $9 depending on pharmacy location [20]. The coupon is free, requires no enrollment, and can be used an unlimited number of times. Pharmacists are required to accept it in place of insurance at their discretion, though most major chains (CVS, Walgreens, H-E-B, Walmart) accept GoodRx routinely.

SingleCare and RxSaver offer comparable pricing and may outperform GoodRx at specific Texas pharmacies. Patients should check two or three cards at the same pharmacy to find the lowest price on a given fill date, since contracted rates change quarterly.

Pfizer does not maintain a broad patient assistance program for Norvasc now that generic competition has made the drug widely affordable. The Pfizer RxPathways program primarily covers other branded Pfizer products. Patients specifically seeking brand Norvasc for a documented intolerance to generic excipients should contact Pfizer directly at 1-844-989-PATH.

NeedyMeds, a nonprofit database updated monthly, lists Texas-specific patient assistance programs and state pharmaceutical assistance programs that may apply to amlodipine [21]. As of 2025, Texas does not operate a state pharmaceutical assistance program (SPAP) independent of Medicaid, so Medicaid-ineligible patients rely entirely on manufacturer and discount-card programs.

The Health Insurance Premium Payment (HIPP) program through Texas Medicaid can sometimes help Medicaid-eligible patients maintain employer-sponsored insurance that covers amlodipine on Tier 1, effectively giving them $0 copays while Medicaid pays the premium. Eligibility is income-based and requires application through Texas Health and Human Services [22].

How Amlodipine Fits Into Texas Hypertension Treatment Pathways

Texas had an age-adjusted hypertension prevalence of 34.1% among adults as of the most recent CDC Behavioral Risk Factor Surveillance System data, above the national average of 32.4% [23]. That prevalence, combined with Texas's large uninsured population (about 16.6% as of 2023, the highest state rate in the US), means cost-sensitive prescribing of antihypertensives has direct public health importance [24].

The 2018 ACC/AHA Hypertension Guidelines recommend initiating pharmacotherapy for Stage 1 hypertension (systolic 130 to 139 mmHg or diastolic 80 to 89 mmHg) in patients with established cardiovascular disease or 10-year ASCOT risk above 10%, and for all adults with Stage 2 hypertension (systolic 140 mmHg or above) [4]. Amlodipine 5 mg daily is a standard starting dose, with titration to 10 mg daily after four weeks if blood pressure targets are not met.

For Black patients with hypertension, who make up a significant portion of Texas's hypertensive population, guidelines specifically note that thiazide diuretics and dihydropyridine CCBs (including amlodipine) perform better for blood pressure lowering than ACE inhibitors or ARBs used as monotherapy. The ALLHAT trial data support this recommendation, showing that amlodipine and chlorthalidone both reduced stroke risk more effectively than lisinopril in Black participants [15]. Given amlodipine's $8 monthly cost in Texas, cost is not a barrier that should prevent appropriate initiation.

Patients with concurrent stable angina benefit from amlodipine's anti-anginal properties independent of its antihypertensive effect. The drug reduces myocardial oxygen demand by causing peripheral vasodilation and reducing afterload, with coronary vasodilatory effects that make it effective for both effort-induced and vasospastic angina [1]. The FDA label specifies 5 to 10 mg once daily for both indications [1].

Common adverse effects include peripheral edema (occurring in 10.8% of patients at 10 mg in clinical trials), flushing, and palpitations [1]. Edema tends to be dose-dependent and can be mitigated by adding an ACE inhibitor or ARB, a strategy validated in ACCOMPLISH (N=11,506), which showed the benazepril-amlodipine combination reduced cardiovascular events by 19.6% more than benazepril-hydrochlorothiazide (P<0.001) [25].

Hepatic impairment slows amlodipine clearance substantially. Patients with severe hepatic disease should start at 2.5 mg daily and titrate slowly, as the prescribing information recommends, because half-life can extend beyond 60 hours in this population [1].

Drug interactions are limited compared to other antihypertensives. Amlodipine is a CYP3A4 substrate; strong CYP3A4 inhibitors such as clarithromycin, itraconazole, and ritonavir may increase amlodipine exposure and blood pressure-lowering effect [3]. Simvastatin co-administration is capped at 20 mg daily when combined with amlodipine 10 mg daily per FDA drug interaction guidance, due to increased simvastatin AUC [2].

Patients with Texas STAR+PLUS (Medicaid managed care for adults with disabilities) should ask their plan's case manager whether a medical necessity exception can be filed for amlodipine coverage, particularly if the patient has documented intolerance to lisinopril (cough) and chlorthalidone (hypokalemia). Exception pathways exist in most managed care contracts and require prescriber documentation of the clinical rationale.

If you are in Texas, pay cash, and take amlodipine 5 mg or 10 mg once daily, present a GoodRx or SingleCare coupon at an H-E-B, Walmart, or Costco pharmacy. Expect to pay between $4 and $8 for a 30-day supply, which is the lowest sustainable out-of-pocket cost currently available in this state for this drug.